Article Sidebar
Published:
Jun 2, 2017Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Synthesis, characterization and pharmacological evaluation of mixed ligand-metal complexes containing omeprazole and 8-hydroxyquinoline
Abstract
Purpose: To synthesize a series of mixed ligand-metal complexes and to evaluate their alkaline phosphatase inhibitory capacities, antioxidant potential and antimicrobial activities.
Method: Mixed ligand-metal complexes of Zn (II), Ni (II), Co (II), Cu (II), omeprazole and 8- hydroxyquinoline were synthesized. The ligand-metal complexes were characterized by various physicochemical techniques, including elemental analysis, magnetic susceptibility, scanning electron microscope (SEM), mass spectrometry (EI-MS), ultraviolet-visible (UV-Vis) spectrophotometry, Fourier transform infrared spectroscopy (FTIR), proton nuclear magnetic resonance (1H-NMR) and conductance studies. The new compounds were also investigated for their alkaline phosphatase (ALPs) inhibition, 2,2’-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging and antimicrobial activities.
Results: Spectroscopic studies revealed the chemical composition of synthesized compounds as well as the bidentate bonding behavior of the coordinating ligands with metal ions. Conductance measurement suggested that the metal complexes were non-electrolytes. Ni(II) complex exhibited antioxidant activity (30.48 ± 0.32 μM) higher than those of BHT (standard) and other complexes. Stronger inhibition of ALPs by Ni (II) mixed ligand complex compared to the other complexes was evident. The synthesized compounds showed moderate to very good antimicrobial activity against bacterial strains, i.e., Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Actinomyces viscosus, Staphylococcus aureus, Bacillus subtilis; as well as against the fungal strains, Candida albicans, Aspergillus flavus and Aspergillus niger.
Conclusion: All the mixed ligand complexes demonstrate higher antioxidant, ALPs-inhibitory and antimicrobial activities than their corresponding ligands. This indicates their therapeutic potential as future drug candidates for the concerned diseases.
Keywords: Omeprazole, 8-Hydroxyquinoline, Mixed-ligand complexes, Alkaline phosphatase, Bidentate bonding behaviors
